Concurrent Use of Opioids and Benzodiazepines (CUOB)
Please wait...
The percentage of Medicaid members age 18 and older with concurrent use of prescription opioids and benzodiazepines. Patients with a cancer diagnosis, sickle cell disease diagnosis,
or in hospice or palliative care are excluded.
Measure Identifier: CMS_A_CUOB
Print | PDF
Please see Report Details below for more information on selected subgroups, organizations, and aggregation.
Tables
Data
Measure Details
Measure Details
Comparator Details
LICENSE AGREEMENTS AND ACKNOWLEDGMENTS
The American Medical Association (AMA) and the American Hospital Association (AHA) permit the use of Current Procedural Terminology (CPT) and National Uniform Billing Committee (NUBC) UB-04 codes solely for the purpose of reporting state data on Medicaid and CHIP Core Set measures to the Centers for Medicare & Medicaid Services (CMS).
The National Committee for Quality Assurance (NCQA), the Pharmacy Quality Alliance (PQA), and the National Association of State Directors of Developmental Disabilities Services (NASDDDS)/Human Services Research Institute (HSRI) permit the use of their technical specifications solely for the purpose of reporting state data on Medicaid and CHIP Core Set measures to the Centers for Medicare & Medicaid Services (CMS). The U.S. Office of Population Affairs (OPA) permits the use of their technical specifications for the purpose of reporting state data on their measures to the OPA or Centers for Medicare & Medicaid Services (CMS). The Substance Abuse and Mental Health Services Administration (SAMHSA) permits the use of their technical specifications for the purpose of reporting data on their measures to SAMHSA or CMS. The Health Resources and Services Administration (HRSA) permits the use of their technical specifications for the purpose of reporting state data on their measures to HRSA or CMS.
For Proprietary Codes in the Adult Core Set:
CPT® codes, descriptions and other data only are copyright 2024 American Medical Association (AMA). All rights reserved. CPT is a trademark of the American Medical Association. Applicable FARS/HHSARS restrictions apply to government use. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
The Uniform Billing Codes (UB) are Copyright © 2024, the American Hospital Association (AHA), Chicago, Illinois. The UB Codes are included with the permission of the AHA. All uses of the UB Codes may require a license from the AHA. Specifically, anyone desiring to use the UB Codes in a commercial manner must obtain a commercial use license directly from the AHA. To inquire about licensing, contact ub04@aha.org.
Some measure specifications contain coding from LOINC® (https://loinc.org). The LOINC table, LOINC codes, LOINC panels and form file, LOINC linguistic variants file, LOINC/RSNA Radiology Playbook, and LOINC/IEEE Medical Device Code Mapping Table are copyright © 1995–2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and available at no cost under the license at https://loinc.org/kb/license/.
“SNOMED” and “SNOMED CT” are registered trademarks of the International Health Terminology Standards Development Organisation (IHTSDO).
“HL7” is the registered trademark of Health Level Seven International.
For NCQA measures in the Adult Core Set:
HEDIS® is a registered trademark of the National Committee for Quality Assurance (“NCQA”). The HEDIS measures and specifications are owned by NCQA. NCQA holds a copyright in these materials and may rescind or alter these materials at any time. Users of the HEDIS measures and specifications shall not have the right to alter, enhance or otherwise modify the HEDIS measures and specifications, and shall not disassemble, recompile, or reverse engineer the HEDIS measures and specifications. Anyone desiring to use or reproduce the materials without modification for the sole purpose of Core Set reporting may do so without obtaining any approval from NCQA. All other uses, including a commercial use (including but not limited to vendors using the measures and specifications with a product or service tocalculate measure results), must be approved by NCQA and are subject to a license at the discretion of NCQA.
HEDIS measures and specifications are not clinical guidelines, do not establish a standard of medical care and have not been tested for all potential applications. The measures and specifications are provided “as is” without warranty of any kind. NCQA makes no representations, warranties or endorsements about the quality of any product, test or protocol identified as numerator compliant or otherwise identified as meeting the requirements of a HEDIS measure or specification. NCQA also makes no representations, warranties or endorsements about the quality of any organization or clinician who uses or reports performance measures. NCQA has no liability to anyone who relies on HEDIS measures and specifications or data reflective of performance under such measures and specifications.
Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. NCQA disclaims all liability for use or accuracy of any coding contained in the specifications.
CPT® codes copyright 2024 American Medical Association. All rights reserved. CPT is a trademark of the American Medical Association. Applicable FARS/HHSARS restrictions apply to government use. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
The American Hospital Association holds a copyright to the Uniform Billing Codes (UB) contained in the HEDIS Value Set Directory (VSD). The UB Codes are included with the permission of the AHA. All uses of the UB Codes may require a license from the AHA. Specifically, anyone desiring to use the UB Codes in a commercial manner to generate measure results or for any other commercial use, must obtain a commercial use license directly from the AHA. To inquire about licensing, contact ub04@aha.org.
NCQA Measure Certification Notice:
A calculated measure result (a “rate”) from a HEDIS measure that has not been certified via NCQA’s Measure Certification Program, and is based on unadjusted HEDIS specifications, may not be called a “Health Plan HEDIS rate” until it is audited and designated reportable by an NCQA-Certified HEDIS Compliance Auditor. Until such time, such measure rates shall be designated or referred to as “Uncertified, Unaudited Health Plan HEDIS Rates.”
© 2024 by the National Committee for Quality Assurance, all rights reserved.
For the CMS Screening for Depression and Follow-up Plan measure in the Adult Core Set:
These performance measures are not clinical guidelines and do not establish a standard of medical care and have not been tested for all potential applications.
THE MEASURE AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND.
Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets.
CPT® contained in the Measure specifications is copyright 2004–2023 American Medical Association. LOINC® is copyright 2004–2023 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms® (SNOMED CT®) copyright 2004–2023 International Health Terminology Standards Development Organisation. ICD-10 is copyright 2023 World Health Organization. All Rights Reserved.
For the AHRQ Quality Indicator measures in the Adult Core Set:
The Agency for Healthcare Research and Quality (AHRQ) Quality Indicators are products of the Federal government, and thus not covered by copyright within the United States. They are publicly available for noncommercial use or adaptation without further permission. However, foreign copyrights may apply, requiring written permission for use outside the U.S. Use of the trademark to identify the source of the AHRQ QIs should follow your organization’s editorial style. Please contact the AHRQ Office of Communications (Ask AHRQ (AHRQ/OC) AskAHRQ@ahrq.hhs.gov) for written permission regarding commercial use (e.g., reprinting in a professional journal or book; incorporation into commercial software; use in for-profit training courses).
For the PQA measures in the Adult Core Set:
PQA, Inc. retains all rights of ownership to the PQA measure specifications and value sets and can rescind or alter the measures at any time. No use of any PQA measure is authorized without prior PQA approval of such use. All uses of PQA measures are subject to such conditions as PQA specifies, and certain uses of the measures may be subject to a licensing agreement specifying the terms of use and the licensing fee. Users of the measure shall not have the right to alter, enhance, or otherwise modify the measures.
By agreeing to this statement, user accepts the following limitations of the use of the PQA measures: User acknowledges that the PQA measure specifications and value sets will only be used for the sole purpose of reporting state data on Medicaid and CHIP Core Set measures to the Centers for Medicare & Medicaid Services (CMS) and will not be used for other purposes. Except for the purpose indicated above, the PQA measure specifications and value sets will not be used in any other commercial product, service, or value-added benefit. User also acknowledges that the PQA value sets will not be forwarded or provided to anyone outside of their organization.
For the SAMHSA Use of Pharmacotherapy for Opioid Use Disorder measure in the Adult Core Set:
The Use of Pharmacotherapy for Opioid Use Disorder (OUD) measure is maintained by RTI International for the Substance Abuse and Mental Health Services Administration (SAMHSA) through the Maintaining Quality Measures contract, Task Order 75S20322D00028/75S20324F42001 (Ref. No. 283-22-2801).
For Proprietary Codes:
Limited proprietary coding is contained in the measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets. RTI disclaims all liability for use or accuracy of any CPT or other codes contained in the specifications. Professional organizations frequently update their codes. Code lists for calculation of this measure were accurate as of August 2024.
The International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) is published by the World Health Organization (WHO). ICD-10-CM is an official Health Insurance Portability and Accountability Act standard.
Level II HCPCS codes in these specifications are approved and maintained jointly by the Alpha-Numeric Panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association.)
The National Drug Code (NDC) Directory is published by the U.S. Food and Drug Administration and is made available under the Open Database License at https://opendatacommons.org/licenses/odbl/1.0/. Any rights in individual contents of the database are licensed under the Database Contents License at https://opendatacommons.org/licenses/dbcl/1.0/.
For the National Association of State Directors of Developmental Disabilities Services (NASDDDS)/Human Services Research Institute (HSRI) measure in the Adult Core Set:
NCI® and National Core Indicators® are registered trademarks of NASDDDS and HSRI. The National Core Indicators-Intellectual and Developmental Disabilities (NCI-IDD) measures and specifications were developed by and are owned by the National Association of State Directors of Developmental Disabilities Services (NASDDDS) and Human Services Research Institute (HSRI). NASDDDS and HSRI hold a copyright on all materials associated with the NCI-IDD measures and specifications and may rescind or alter these measures and specifications at any time. Users of the NCI-IDD measures and specifications shall not have the right to alter, enhance, or otherwise modify the NCI-IDD measures and specificationsor associated materials. Anyone desiring to use or reproduce the contents of reports, inclusive of data results, without modification for a non-commercial purpose, may do so without obtaining approval from NASDDDS/HSRI. The use or reproduction of NCI-IDD survey instruments and questions requires prior approval by the NASDDDS and HSRI. All commercial uses or requests for alteration of the measures and specifications must be approved by NASDDDS/HSRI and are subject to a license at the discretion of NASDDDS/HSRI. NCI-IDD measures and specifications are not clinical or disability services guidelines, do not establish a standard of medical care, nor a standard for disability services and are not intended or tested for all potential applications.
The measures and specifications are provided “as is” without warranty of any kind. NASDDDS and HSRI make no representations, warranties, or endorsements about the suitability or utility of any product, test, or protocol identified as deriving from or based on an NCI-IDD measure or specification. NASDDDS/HSRI also makes no representations, warranties, or endorsements about the quality of any agency of a state, contractor of a state agency, or other organization who uses, applies, or reports NCI performance measures. NASDDDS/HSRI has no liability to anyone who relies on NCI-IDD measures and specifications or data reflective of performance under such measures and specifications.
For the Dental Quality Alliance measures in the Adult Core Set:
2025 American Dental Association on behalf of the Dental Quality Alliance (DQA) ©. All rights reserved. Use by individuals or other entities for purposes consistent with the DQA’s mission and that is not for commercial or other direct revenue generating purposes is permitted without charge.
Dental Quality Alliance Measures (Measures) and related data specifications, developed by the Dental Quality Alliance (DQA), are intended to facilitate quality improvement activities.
These Measures are intended to assist stakeholders in enhancing quality of care. These performance Measures are not clinical guidelines and do not establish a standard of care. The DQA has not tested its Measures for all potential applications.
Measures are subject to review and may be revised or rescinded at any time by the DQA. The Measures may not be altered without the prior written approval of the DQA. The DQA shall be acknowledged as the measure steward in any and all references to the Measures. Measures developed by the DQA, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and DQA. Neither the DQA nor its members shall be responsible for any use of these Measures.
THE MEASURES ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND.
Limited proprietary coding is contained in the Measure specifications for convenience.
For Proprietary Codes:
These materials contain Current Dental Terminology (CDT). The Code on Dental Procedures and Nomenclature have been obtained from CDT (including procedure codes, nomenclatures, descriptors, and other data contained therein). Current Dental Terminology (CDT), Copyright © 2024 American Dental Association (ADA). All rights reserved. CDT is a trademark of the ADA. Applicable FAR/HHSAR apply.
This material contains National Uniform Claim Committee (NUCC) Health Care Provider Taxonomy codes (http://www.nucc.org/index.php?option=com_content&view=article&id=14&Itemid=125). Copyright © 2024 American Medical Association. All rights reserved.
Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The DQA, American Dental Association (ADA), and its members disclaim all liability for use or accuracy of any terminologies or other coding contained in the specifications.
THE SPECIFICATIONS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND.
For Codes in the Public Domain used in the Adult Core Set measures:
The International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) is published by the World Health Organization (WHO). ICD-9-CM is an official Health Insurance Portability and Accountability Act standard.
The International Classification of Diseases, 9th Revision, Procedure Coding System (ICD-9-PCS) is published by the World Health Organization (WHO). ICD-9-PCS is an official Health Insurance Portability and Accountability Act standard.
The International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) is published by the World Health Organization (WHO). ICD-10-CM is an official Health Insurance Portability and Accountability Act standard.
The International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) is published by the World Health Organization (WHO). ICD-10-PCS is an official Health Insurance Portability and Accountability Act standard.
The National Drug Code (NDC) Directory is published by the U.S. Food and Drug Administration and is made available under the Open Database License at https://opendatacommons.org/licenses/odbl/1.0/. Any rights on individual contents of the database are licensed under the Database Contents License at https://opendatacommons.org/licenses/dbcl/1.0/.